Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New studies offer evidence that an unexpected virus plays a role—but it needs a helper.
Children with non-alcoholic fatty liver disease need to be closely observed to help combat type 2 diabetes later in life.
After a long wait, the FDA authorizes Pfizer and Moderna vaccines for children as young as 6 months old.
As unexplained hepatitis cases in children rise globally, countries must unite to eliminate viral hepatitis.
The current leading suspect is an adenovirus, but much more remains to be learned.
Noninvasive imaging may be the best way to screen for NAFLD in this population.
Intensive lifestyle management led to weight loss and reduced steatosis and fibrosis.
Vaccine effectiveness for children ages 5 to 11 was 91%, and serious side effects are rare.
The Pfizer-BioNTech vaccine was 100% effective in a study of adolescents; trials for younger children are now underway.
Kids can have a high coronavirus viral load, which makes them more contagious.
Children can contract the virus, although they usually have no symptoms or mild illness.
Teenagers are attempting suicide with opioids at increasing rates.
There is a strong association between the prevalence of the virus among adults and its prevalence among children.
New Hepatitis C Screening recommendations should grow from the knowledge we have, and correctly reflect the needs of the community.
Ninety-seven percent of the children were cured of hepatitis C.
The U.S. FDA approved hepatitis C treatment Mavyret for children from ages 12 to 17 with all genotypes.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.